rs144598063
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_001130987.2(DYSF):c.3175C>T(p.Arg1059Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000206 in 1,613,926 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001130987.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DYSF | NM_001130987.2 | c.3175C>T | p.Arg1059Cys | missense_variant | 29/56 | ENST00000410020.8 | NP_001124459.1 | |
DYSF | NM_003494.4 | c.3121C>T | p.Arg1041Cys | missense_variant | 29/55 | ENST00000258104.8 | NP_003485.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DYSF | ENST00000410020.8 | c.3175C>T | p.Arg1059Cys | missense_variant | 29/56 | 1 | NM_001130987.2 | ENSP00000386881.3 | ||
DYSF | ENST00000258104.8 | c.3121C>T | p.Arg1041Cys | missense_variant | 29/55 | 1 | NM_003494.4 | ENSP00000258104.3 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152202Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000168 AC: 42AN: 250558Hom.: 0 AF XY: 0.000155 AC XY: 21AN XY: 135582
GnomAD4 exome AF: 0.000213 AC: 311AN: 1461724Hom.: 1 Cov.: 32 AF XY: 0.000208 AC XY: 151AN XY: 727170
GnomAD4 genome AF: 0.000138 AC: 21AN: 152202Hom.: 0 Cov.: 33 AF XY: 0.000148 AC XY: 11AN XY: 74350
ClinVar
Submissions by phenotype
not provided Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jun 19, 2021 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Dec 29, 2017 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2023 | DYSF: PM2, PM3, PP3 - |
Autosomal recessive limb-girdle muscular dystrophy type 2B Uncertain:3
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Jan 10, 2020 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Nov 01, 2023 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | Feb 22, 2017 | - - |
Qualitative or quantitative defects of dysferlin Pathogenic:1Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | The DYSF c.3121C>T (p.Arg1041Cys) variant has been reported in one study and is found in one patient with Miyoshi muscular dystrophy in a homozygous state (Kawabe et al. 2004). The p.Arg1041Cys variant was absent from 120 control chromosomes and is reported at a frequency of 0.00047 in the European American population of the Exome Sequencing Project. Based on the evidence, the p.Arg1041Cys variant is classified as a variant of unknown significance but suspicious for pathogenicity for dysferlinopathy. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 1041 of the DYSF protein (p.Arg1041Cys). This variant is present in population databases (rs144598063, gnomAD 0.04%). This missense change has been observed in individual(s) with limb-girdle muscular dystrophy and/or Miyoshi myopathy (PMID: 15469449, 33610434). ClinVar contains an entry for this variant (Variation ID: 286743). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on DYSF protein function. For these reasons, this variant has been classified as Pathogenic. - |
DYSF-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 10, 2024 | The DYSF c.3121C>T variant is predicted to result in the amino acid substitution p.Arg1041Cys. This variant has been reported in the homozygous state in an individual with Miyoshi myopathy (Kawabe et al. 2004. PubMed ID: 15469449). This variant has also been reported in the compound heterozygous state in two additional individuals with dysferlinopathy and reduced or absent dysferlin on muscle biopsy; however one of the individuals also harbored a third DYSF variant (Table S1 in Moore et al. 2021. PubMed ID: 33610434). This variant is reported in 0.037% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Additionally, gnomAD v.4.1.0 reports a homozygous individual (https://gnomad.broadinstitute.org/variant/2-71570688-C-T?dataset=gnomad_r4). Given the conflicting evidence, at this time, the clinical significance of this variant is uncertain. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at